Evaluation
*
*

Thinking about the impact of this session on your patients, please offer an estimate of the:

*
%
*
/month
*
1 (Disagree)2345 (Agree)
Understand FDA regulatory principles with respect to trial design, end points, randomization, and accelerated approval programs
Differentiate among various end points used in clinical trial design and understand their strengths and weaknesses
Discuss emerging initiatives in the quest to expedite the drug development process
*
1 (Low)2345 (High)
Richard Pazdur, MD
*
*